Ładuje się......
From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research
Treatment of Myasthenia Gravis (MG) is still based on non-specific immunosuppression. Long-term high dose corticosteroids is still a major cause of side effects, in young as well as in elderly patients in whom comorbidities further increase the burden of chronic immunosuppression. Moreover, awarenes...
Zapisane w:
| Wydane w: | Front Neurol |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492201/ https://ncbi.nlm.nih.gov/pubmed/32982957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00981 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|